Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ · Financial Services
Bellevue Life Sciences Acquisition Corp. Operating Income 2021–2023
Bellevue Life Sciences Acquisition Corp. annual/quarterly operating income history and growth rate from 2021 to 2024. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Bellevue Life Sciences Acquisition Corp. operating income for the quarter ending September 30, 2024 was -454132, a 10.65% increase year-over-year.
- Bellevue Life Sciences Acquisition Corp. operating income for the twelve months ending September 30, 2024 was -2.2 M.
- Bellevue Life Sciences Acquisition Corp. annual operating income for 2023 was -1.8 M, a 5073.22% increase from 2022.
- Bellevue Life Sciences Acquisition Corp. annual operating income for 2022 was -35388, a 969.77% increase from 2021.
- Bellevue Life Sciences Acquisition Corp. annual operating income for 2021 was -3308.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bellevue Life Sciences Acquisition Corp. Operating Income — FAQ
Bellevue Life Sciences Acquisition Corp. (BLAC) operating income over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Bellevue Life Sciences Acquisition Corp.'s operating income?
Bellevue Life Sciences Acquisition Corp. (BLAC) reported operating income of -$2M for fiscal 2023.
Where can I see BLAC's operating income history?
The chart and table above show Bellevue Life Sciences Acquisition Corp.'s operating income by year and by quarter, including the growth rate.